Delivery Order SPE2DX15D3012-SPE2DX24F8EF3
- Not listed
- This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is a Delivery Order with a Firm Fixed Price pricing type, valued at $1,232.96. It is for the supply of ROCURONIUM 100 MG/10 ML VIAL 10ML, a medical product, to support defense agency medical requirements. The contract has an ultimate completion date of May 29, 2025. Amerisourcebergen Drug Corp is the...
- This federal contract award, valued at $2,693.25, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of 4560348396 - ROCURONIUM 50 MG/5 ML VIAL 5ML, a critical medical product. The contract is a Delivery Order under a larger Indefinite Delivery Contract (IDC) valued at up to $999,999,999.00, which Amerisourcebergen's parent company Cencora, Inc. holds with the...
- This is a federal contract award made by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The award, valued at $1,105.56, is for the delivery of ROCURONIUM 100 MG/10 ML VIAL 10ML medical supplies. The contract is a Delivery Order under an Indefinite Delivery Contract (IDC) valued at $999,999,999 held by Amerisourcebergen with the DLA Troop Support Medical. This IDC serves as a primary...
- This federal contract award was made by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $10,402.97 firm fixed-price delivery order is for the supply of 4564616857 - ROCURONIUM 50 MG/5 ML VIAL 5ML. The contract has a completion date of May 16, 2024. Amerisourcebergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a primary vehicle...
- This is a $6,913.35 firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the supply of 4567554876 - ROCURONIUM 50 MG/5 ML VIAL 5ML, a type of medication, to support military healthcare programs. The order has a period of performance through March 13, 2025. AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with DLA Troop Support...
- This federal contract award is for the delivery of ROCURONIUM 100 MG/10 ML VIAL 10ML to the Medical Supply Chain, a component of the Defense Logistics Agency (DLA). The $1,128.03 firm-fixed-price delivery order was awarded to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, on August 9, 2024, with a final completion date of August 12, 2024. This contract is not associated with a set-aside program. Amerisourcebergen holds several indefinite delivery contracts (IDCs) with the DLA...
- This is a federal contract award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The award is for the delivery of 4566842965 ROCURONIUM 100 MG/10 ML VIAL 10ML, a pharmaceutical product, with a ceiling value of $1,980.18 and a period of performance through January 7, 2025. The contract is a Delivery Order issued under AmerisourceBergen's existing Indefinite Delivery Contract (IDC) with the DLA Troop...
- This federal contract award was issued by the Defense Logistics Agency (DLA) Troop Support Medical to AmerisourceBergen Drug Corporation, a major pharmaceutical distributor, for the delivery of 4,565,377,731 units of the drug Rocuronium 100 mg/10 ml vial (10 ml). The firm-fixed-price delivery order, valued at $1,128.03, has an ultimate completion date of August 8, 2024. This award is part of a larger Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at up to...
- This federal contract award to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, provides for the delivery of Rocuronium 50 mg/5 ml vials. The $1,374.24 firm-fixed-price delivery order was issued by the Defense Logistics Agency (DLA) Troop Support Medical, a component of the U.S. Department of Defense. The award is associated with a larger Indefinite Delivery Contract (IDC) held by Amerisourcebergen with the DLA, valued at $999,999,999 and running through November 2026. This IDC...
- This federal contract award was issued by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a major pharmaceutical distributor. The $1,526.74 Firm Fixed Price Delivery Order contract is for the supply of 4566319471 - Rocuronium 100 mg/10 ml vials. The award is not designated as a set-aside and does not reference a larger indefinite delivery vehicle. Amerisourcebergen maintains a $999,999,999 Indefinite Delivery Contract with DLA Troop Support Medical for...
- SPE2DX15D3012Indefinite Delivery Contract
- SPE2DX15D3012-SPE2DX24F8EF3Delivery Order
This federal contract award, valued at $1,104.49, was issued by the Defense Logistics Agency (DLA) to the prime contractor Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, a Delivery Order under a larger Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, is for the delivery of ROCURONIUM 50 MG/5 ML VIAL 5ML, a medical supply. The contract has a period of performance through November 21, 2023 and is a Firm Fixed Price arrangement. No set-aside designation was used for this award. Amerisourcebergen holds a significant $999,999,999 IDC with the DLA Troop Support Medical, as well as a $750,000 IDC with the Department of Justice Federal Bureau of Investigation, both of which provide a comprehensive range of pharmaceutical products and medical supplies to support federal healthcare programs.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $1.1k | 11/20/23 |